Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Savary dilation with triamcinolone versus placebo injections for benign esophageal anastomotic strictures
NL-OMON35193Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anastomotic esophageal stricture comparing Savary dilation + saline placebo with Savary dilation + triamcinolone (2 arms). Primary endpoints: Median time to repeat dilation and Success rate after 6 months follow-up. Started Feb 2010; status: active, not recruiting.
02
Drugs
triamcinolone
03
Conditions
anastomotic esophageal stricture
Beyond the preview
Go deeper on NL-OMON35193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35193.